Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
06/30/2011 | US20110160445 Heparin-Binding Growth Factor (HBGF) Polypeptides |
06/30/2011 | US20110160444 Cloning Transcription Factor Gene OsWOX20 That Regulates The Growth and Development of Monocotyledon's Root and Uses Thereof |
06/30/2011 | US20110160443 Rna aptamers and methods for identifying the same |
06/30/2011 | US20110160440 Cab Molecules |
06/30/2011 | US20110160438 Il-17 receptor like molecules and uses thereof |
06/30/2011 | US20110160293 Prmt1 for target genes of cancer therapy and diagnosis |
06/30/2011 | US20110160291 Oligonucleotide Compositions and Their Use to Induce Apoptosis |
06/30/2011 | US20110160289 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
06/30/2011 | US20110160288 Oip5 as a target gene for cancer therapy and diagnosis |
06/30/2011 | US20110160287 Potentiator of activity of anti-cancer agent and use thereof, and biomarker for prediction of prognosis in cancer patient and use thereof |
06/30/2011 | US20110160283 Modulation of cd40 expression |
06/30/2011 | US20110160282 Nucleic-acid pharmaceutical composition for cancer therapy |
06/30/2011 | US20110160281 RNA Interference Mediated Inhibition of Vascular Cell Adhesion Molecule (VCAM) Gene Expression Using Short Interfering Nucleic Acid (siNA) |
06/30/2011 | US20110160280 Cancer-related genes, cdca5, epha7, stk31 and wdhd1 |
06/30/2011 | US20110160277 Modulation of 11 beta-hydroxysteriod dehydrogenase 1 expression for the treatment of ocular diseases |
06/30/2011 | US20110160135 Suppression of neuroendocrine diseases |
06/30/2011 | US20110160126 Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders |
06/30/2011 | US20110160122 Polypeptides having Antimicrobial Activity and Polynucleotides Encoding Same |
06/30/2011 | US20110160093 Detection and quantification of biomolecules using mass spectrometry |
06/30/2011 | US20110160091 Methods and Nucleic Acids for Analyses of Cell Proliferative Disorders |
06/30/2011 | US20110160086 Gene expression signature for classification of kidney tumors |
06/30/2011 | US20110160082 Mobility-Modified Nucleobase Polymers and Methods of Using Same |
06/30/2011 | US20110160076 Methods for producing uniquely specific nucleic acid probes |
06/30/2011 | US20110160072 Method of diagnosing neoplasms |
06/30/2011 | US20110160071 Novel Proteins and Methods for Designing the Same |
06/30/2011 | US20110159586 Compositions and methods for modulating gene expression using asymmetrically-active precursor polynucleotides |
06/30/2011 | US20110159571 Adenovirus targeting |
06/30/2011 | US20110159569 Anti-nucleic acid antibody inducing cell death of cancer cells and composition for preventing or treating cancers comprising the same |
06/30/2011 | US20110159555 Methods, Chimeric Polypeptides, Polynucleotides and Cells for Producing Bioplastics |
06/30/2011 | US20110159553 Methods for Detection of Micro RNA Molecules |
06/30/2011 | US20110159552 Lactic acid bacteria-derived double-stranded rna |
06/30/2011 | US20110159545 Fungamyl-like Alpha-Amylase Variants |
06/30/2011 | US20110159544 Method for treating cellulosic material and CBHII/CEL6A enzymes useful therein |
06/30/2011 | US20110159542 Immunosuppressive polypeptides and nucleic acids |
06/30/2011 | US20110159541 Methods and compositions for inactivating alpha 1,6 fucosyltransferase (FUT8) gene expression |
06/30/2011 | US20110159540 Methods for Chemically Synthesizing Immunoglobulin Chimeric Proteins |
06/30/2011 | US20110159537 Synthetic pathway enzymes for the production of argyrins |
06/30/2011 | US20110159529 Fusion protein having luminescence activity |
06/30/2011 | US20110159520 Hybrid proteins comprising membrane receptor and ion channel, and their use as biosensors |
06/30/2011 | US20110159518 Method for the diagnosis of the presence of an ovarian cancer |
06/30/2011 | US20110159514 Biomarker for osteoarthritis and/or other ageing-related diseases, and use thereof |
06/30/2011 | US20110159512 Polynucleotide sequences of candida dubliniensis and probes for detection |
06/30/2011 | US20110159503 Dna extraction method for bursaphelenchus xylophilus from wood chips, lamp primer set for bursaphelenchus xylophilus, and detection method for bursaphelenchus xylophilus from wood chips |
06/30/2011 | US20110159499 Methods and compositions for detecting genetic material |
06/30/2011 | US20110159493 Diagnostic polymorphisms for cardiac disease |
06/30/2011 | US20110159488 Primers for Amplification and Sequencing of Eubacterial 16S rDNA for Identification |
06/30/2011 | US20110159486 Cell cycle switch 52(ccs52) and methods for increasing yield |
06/30/2011 | US20110159168 Non-transgenic Tomato Varieties Having Increased Shelf Life Post-Harvest Due to Alterations in Beta-Galactosidase 4 |
06/30/2011 | US20110159081 Vaccine |
06/30/2011 | US20110159041 Chlamydia Trachomatis Genomic Sequence and Polypeptides, Fragments Thereof and Uses Thereof, in Particular for the Diagnosis, Prevention and Treatment of Infection |
06/30/2011 | US20110159021 Xbp1, cd138, and cs1 peptides |
06/30/2011 | US20110159020 Transcription Factor for Killer Cell Activation, Differentiation and Uses Thereof |
06/30/2011 | US20110159018 Complement factor h-derived short consensus repeat-antibody constructs |
06/30/2011 | US20110159009 Anti-vegf antibodies |
06/30/2011 | US20110159008 Antibodies Binding To The Extracellular Domain Of The Receptor Tyrosine Kinase ALK |
06/30/2011 | US20110159001 CROSS-NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES TO SARS-CoV AND METHODS OF USE THEREOF |
06/30/2011 | US20110158999 Antagonists of protease activated receptor-1 (par1) |
06/30/2011 | US20110158997 Single chain fragment variable antibody libraries and uses thereof |
06/30/2011 | US20110158995 Multi-Specific Binding Proteins Targeting B Cell Disorders |
06/30/2011 | US20110158994 Polypeptides specifically binding to vascular endothelial growth factor receptor-2 and methods therefor |
06/30/2011 | US20110158992 Engineered Anti-IL-23R Antibodies |
06/30/2011 | US20110158986 Humanized antibodies that sequester amyloid beta peptide |
06/30/2011 | US20110158977 Immunogenic compositions for Chlamydia trachomatis |
06/30/2011 | US20110158973 Suppression of cancers |
06/30/2011 | US20110158957 Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases |
06/30/2011 | US20110158947 Sulfonylurea receptor and means for treating ischaemia |
06/30/2011 | US20110158937 Synergistic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy |
06/30/2011 | US20110158936 Use of interleukin 17e for the treatment of cancer |
06/30/2011 | US20110158911 Methods for Screening for Antibiotic Compounds |
06/30/2011 | US20110158908 Cyclosporin a-binding protein |
06/30/2011 | US20110158906 Targeted block copolymer micelles |
06/30/2011 | US20110155605 Apo-2 ligand |
06/30/2011 | US20110154581 Polyol oxidases |
06/30/2011 | CA2784344A1 Tsg primer target detection |
06/29/2011 | EP2339029A1 Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma |
06/29/2011 | EP2339028A1 Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma |
06/29/2011 | EP2339025A1 Methods and compositions for determining methylation profiles |
06/29/2011 | EP2339024A1 Methods for quantitative determination of methylation density in a DNA locus |
06/29/2011 | EP2339007A1 Arabidopsis genes encoding proteins involved in sugar and lipid metabolism and methods of use |
06/29/2011 | EP2338990A2 Methods for synthesis of encoded libraries |
06/29/2011 | EP2338895A1 Genetically modified yeast species and fermentation processes using genetically modified yeast |
06/29/2011 | EP2338894A1 Flavivirus fusion inhibitors |
06/29/2011 | EP2338893A1 Labelled nucleotides |
06/29/2011 | EP2338508A1 A rDEN3/4delta 30(ME), rDEN2/4delta30(ME) or rDEN1/4delta30(ME) recombinant chimeric dengue virus containing a 30 nucleotide deletion (delta30) in a section of the 3' untranslated region of dengue type 4 genome, wherein said 30 nucleotide deletion corresponds to the TL2 stem-loop structure. |
06/29/2011 | EP2338499A1 5' triphosphate oligonucleotide induces anti-viral response |
06/29/2011 | EP2337865A1 Improved allele-specific amplification |
06/29/2011 | EP2021472B1 Compounds and methods for modulating gene expression |
06/29/2011 | EP1694850B1 Plasmid system for multigene expression |
06/29/2011 | EP1641944B1 Room temperature elution of nucleic acids |
06/29/2011 | CN1918298B Pharmaceutical composition and method of treatment of human malignancies with arginine deprivation |
06/29/2011 | CN1875111B Production of high mannose proteins in plant culture |
06/29/2011 | CN1863923B Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases |
06/29/2011 | CN1606565B Nucleic acids encoding recominant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
06/29/2011 | CN101367858B Method for quickly extracting and purifying nosophyte DNA in plant disease tissue |
06/29/2011 | CN101186948B Multiple PCR detection method for sugar-cane mosaic disease and ratoon stunting disease pathogeny |
06/28/2011 | US7968768 comprising a plant transformation vector comprising a nucleotide sequence that encodes a DRO3 polypeptide; genetic engineering |
06/28/2011 | US7968767 Antifreeze proteins isolated from forage grasses and methods for their use |
06/28/2011 | US7968766 Plant UDP-galatose epimerases |
06/28/2011 | US7968701 Nylon polyribonucleosides |
06/28/2011 | US7968700 Expression augmenting DNA fragments, use thereof, and methods for finding thereof |